Kuo RN - Search Results

1

Comparative effectiveness of first-line platinum-based chemotherapy regimens for advanced lung squamous cell carcinoma.

Liao BC, Shao YY, Chen HM, Shau WY, Lin ZZ, Kuo RN, Lai CL, Chen KH, Cheng AL, Yang JC, Lai MS. Liao BC, et al. Among authors: kuo rn. Clin Lung Cancer. 2015 Mar;16(2):137-43. doi: 10.1016/j.cllc.2014.09.004. Epub 2014 Sep 30. Clin Lung Cancer. 2015. PMID: 25450871

2

Is quality of colorectal cancer care good enough? Core measures development and its application for comparing hospitals in Taiwan.

Chung KP, Chang YJ, Lai MS, Kuo RN, Cheng SH, Chen LT, Tang R, Liu TW, Shieh MJ. Chung KP, et al. Among authors: kuo rn. BMC Health Serv Res. 2010 Jan 27;10:27. doi: 10.1186/1472-6963-10-27. BMC Health Serv Res. 2010. PMID: 20105287 Free PMC article.

3

Predicting healthcare utilization using a pharmacy-based metric with the WHO's Anatomic Therapeutic Chemical algorithm.

Kuo RN, Dong YH, Liu JP, Chang CH, Shau WY, Lai MS. Kuo RN, et al. Med Care. 2011 Nov;49(11):1031-9. doi: 10.1097/MLR.0b013e31822ebe11. Med Care. 2011. PMID: 21945973

4

Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma.

Shau WY, Shao YY, Yeh YC, Lin ZZ, Kuo R, Hsu CH, Hsu C, Cheng AL, Lai MS. Shau WY, et al. Oncologist. 2012;17(6):856-62. doi: 10.1634/theoncologist.2012-0065. Epub 2012 May 23. Oncologist. 2012. PMID: 22622151 Free PMC article.

5

Re-examining the significance of surgical volume to breast cancer survival and recurrence versus process quality of care in Taiwan.

Kuo RN, Chung KP, Lai MS. Kuo RN, et al. Health Serv Res. 2013 Feb;48(1):26-46. doi: 10.1111/j.1475-6773.2012.01430.x. Epub 2012 Jun 7. Health Serv Res. 2013. PMID: 22670835 Free PMC article.

6

Survival following surgery with or without adjuvant chemotherapy for stage I-IIIA non-small cell lung cancer: an east asian population-based study.

Lin ZZ, Shau WY, Shao YY, Yang YY, Kuo RN, Yang JC, Lai MS. Lin ZZ, et al. Among authors: kuo rn. Oncologist. 2012;17(10):1294-302. doi: 10.1634/theoncologist.2012-0082. Epub 2012 Jul 23. Oncologist. 2012. PMID: 22826374 Free PMC article.

7

Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer.

Shao YY, Shau WY, Lin ZZ, Chen HM, Kuo R, Yang JC, Lai MS. Shao YY, et al. Eur J Cancer. 2013 Jan;49(1):106-14. doi: 10.1016/j.ejca.2012.07.014. Epub 2012 Aug 14. Eur J Cancer. 2013. PMID: 22897841

8

Development and validation of a pharmacy-based comorbidity measure in a population-based automated health care database.

Dong YH, Chang CH, Shau WY, Kuo RN, Lai MS, Chan KA. Dong YH, et al. Among authors: kuo rn. Pharmacotherapy. 2013 Feb;33(2):126-36. doi: 10.1002/phar.1176. Pharmacotherapy. 2013. PMID: 23386595

9

Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality.

Liu CJ, Chu YT, Shau WY, Kuo RN, Chen PJ, Lai MS. Liu CJ, et al. Among authors: kuo rn. Gut. 2014 Mar;63(3):506-14. doi: 10.1136/gutjnl-2012-304370. Epub 2013 May 15. Gut. 2014. PMID: 23676440

10

The influence of socio-economic status and multimorbidity patterns on healthcare costs: a six-year follow-up under a universal healthcare system.

Kuo RN, Lai MS. Kuo RN, et al. Int J Equity Health. 2013 Aug 20;12:69. doi: 10.1186/1475-9276-12-69. Int J Equity Health. 2013. PMID: 23962201 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters